The Oxford/AstraZeneca Covid-19 vaccine may be authorized for emergency use in the US in April, Dr. Moncef Slaoui, chief scientific adviser for Operation Warp Speed, said Wednesday.
The Oxford/AstraZeneca vaccine was authorized for use in the UK Wednesday.
“As you know, that vaccine is in Phase three trials here in the US,” Slaoui said during a briefing. “We have almost totally completed the recruitment of that trial.”
Slaoui said the vaccine is being manufactured ahead of the potential authorization.
“If everything goes well, that read-out and emergency use authorization may be granted somewhere early in April,” he added. “By that time, several tens of millions of doses of this vaccine will have been manufactured.”